A Phase I/II Study of FG-M108 Plus FG-B901 in Advanced CLDN18.2-Positive Solid Tumors

Clinical trial NCT07704866 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07704866
Sponsor: FutureGen Biopharmaceutical (Beijing) Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Claudin 18.2 Solid Tumor Malignancies

Start date: 2026-07-30
Primary completion: 2028-08-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.